Real Clinical Practice Data of Monthly Dupilumab Therapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Clinical Efficacy and Predictive Markers for a Favorable Clinical Response-Reference-Cited by-同舟云学术

Real Clinical Practice Data of Monthly Dupilumab Therapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Clinical Efficacy and Predictive Markers for a Favorable Clinical Response

Published:2021 Issue:5 Volume:13 Page:733
ISSN:2092-7355
Container-title:Allergy, Asthma & Immunology Research
language:en
Short-container-title:Allergy Asthma Immunol Res

Author:

Lee Youngsoo¹^ORCID,Kim Myoung-Eun¹^ORCID,Nahm Dong-Ho¹^ORCID

Affiliation:

1. Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.

Publisher

The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al

Subject

Pulmonary and Respiratory Medicine,Immunology,Immunology and Allergy

Link

https://e-aair.org/pdf/10.4168/aair.2021.13.5.733

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis;Journal of Allergy and Clinical Immunology: Global;2024-11

2. Update of systemic treatments in severe/recalcitrant atopic dermatitis: Consensus document of the KAAACI working group on atopic dermatitis;Allergy, Asthma & Respiratory Disease;2024

3. Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis;Disease Markers;2023-11-01

4. Evaluation of dupilumab dosing regimen in patients with persistently controlled atopic dermatitis;Journal of the European Academy of Dermatology and Venereology;2023-07-21

5. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis;JEADV Clinical Practice;2023-06-23